ODAC said it was. The CRL came down to evidence of the potency of the cells being manufacturer consistently and that has been resolved. All other boxes have been ticked.
Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-315
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.023(2.04%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.12 | $1.911M | 1.688M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 74537 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 15030 | 7 |
View Market Depth
| Last trade - 10.27am 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |